Industry News
Potential New Approach For Treating Graft-Versus-Host-Disease Provided By Natural Enzyme
Jan 19, 2012
A natural enzyme derived from human blood plasma showed potential in significantly reducing the effects of graft-vs.-host disease, a common and deadly side effect of lifesaving bone marrow transplants. Researchers from the University of Michigan Comprehensive Cancer Center looked at the drug alpha-1-antitrypsin, which is approved by the U.S... Read More
Identification Of Essential Protein For The Formation Of New Blood Vessels
Jan 19, 2012
New research explains how cells regulate their bonds during the development of new blood vessels. For the first time, the role of the protein Raf-1 in determining the strength of the bond between cells has been shown. If Raf-1 is not present, the cells cannot stick together and the formation of new blood vessels is inhibited... Read More
Malignant Melanoma Recurrence - How To Avoid It After Targeted Treatment
Jan 18, 2012
According to a study published in the New England Journal of Medicine, researchers at The Institute of Cancer Research (ICR) have demonstrated how to prevent new cancers that can occur when malignant melanoma patients are treated with drugs known as BRAF inhibitors... Read More
Blood Clots After Hip Or Knee Replacement - Study Looks At Prevalence
Jan 18, 2012
According to a study in the January 18 issue of JAMA, approximately 1 in every 100 patients undergoing knee replacement surgery, and 1 in every 200 patients undergoing hip replacement surgery who use current preventive medications for venous thromboembolism (VTE; a blood clot that develops within a vein that might become serious), will develop VTE before being discharged from hospital... Read More
Drug Helps Maintain Platelet Inhibition And Anti-Clotting Levels Prior To Cardiac Surgery
Jan 18, 2012
According to a study in the January 18 issue of JAMA, patients who stop using an antiplatelet agent, such as clopidogrel, before undergoing cardiac surgery to reduce their risk of bleeding and received intravenously the platelet inhibitor cangrelor, achieved a higher rate of maintenance of platelet inhibition than those who were given placebo... Read More
Malignant Melanoma Recurrence - How To Avoid It After Targeted Treatment
Jan 18, 2012
According to a study published in the New England Journal of Medicine, researchers at The Institute of Cancer Research (ICR) have demonstrated how to prevent new cancers that can occur when malignant melanoma patients are treated with drugs known as BRAF inhibitors... Read More
Stopping Prostate Cancer Growth - Breakthrough
Jan 18, 2012
A study by investigators at the Methodist Research Institute at Indiana University confirms that an all-natural, doctor-designed formula is effective in suppressing prostate cancer tumors. The study conducted on mice, used a human prostate cancer xenograft model. Results from the live animal study were presented by lead researcher, Dr... Read More
Scriptaid Revives Breast Cancer Treatment Receptivity
Jan 18, 2012
A study by researchers from the Sbarro Institute for Cancer Research and Molecular Medicine, reveals that despite the effectiveness of endocrine therapy for breast cancer, responsiveness to the treatment depends on expression of estrogen receptors in breast cancer cells. However, Dr... Read More
New Drug For Advanced Colorectal Cancer Shows Promise In Trial
Jan 18, 2012
An experimental drug for advanced colorectal cancer that available treatments have failed to halt, has shown promise in a clinical trial, says Bayer HealthCare, the company that makes it. The results of the phase III trial show that compared to placebo, regorafenib slowed tumor growth and extended survival... Read More
Researchers Elucidate Mechanism By Which Immune Cells Destroy Cancer Cells
Jan 18, 2012
In the treatment of large tumors, how effective is adoptive T cell therapy in comparison to drug-based cancer treatment? To answer this question, Dr... Read More
Previous Page Next Page